Concourse Financial Group Securities’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2372 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4023 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4015 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4054 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4067 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4006 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3971 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3934 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3847 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3812 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3591 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3645 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3592 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3722 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3673 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3572 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3497 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3422 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3264 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3167 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3201 |
|